• 25 million gift establishes the Smilow Center for Precision Therapeutics at Penn Medicine October 07, 2026 The Smilow Foundation’s gift will advance gene editing and other precision therapies for cardiovascular disease.
• Penn researchers honored with NIH Director’s Awards for bold, high-impact research October 06, 2026 Penn researchers earned NIH Director’s Awards supporting innovative studies of disease, housing design, and human health.
• Penn-Wistar collaboration enters a new chapter as Ronny Drapkin takes Wistar’s helm October 05, 2026 After more than a decade at Penn Medicine, cancer researcher Ronny Drapkin, MD, PhD, will join Wistar as President & CEO in November 2026.
• Nearly twice as many people quit smoking when offered cash rewards October 04, 2026 Financial incentives of up to $600 nearly doubled verified quit rates among medically underserved adults undergoing lung cancer screening.
• Three Penn Medicine faculty honored with American College of Physicians awards October 04, 2026 National awards honor three Penn Medicine faculty for contributions to behavioral medicine, health policy, patient care, and scientific discovery.

Use arrow keys to view news

Use arrow keys to view events